Robert Schreiber

Robert Schreiber

Washington University School of Medicine
在 immunology.wustl.edu 的电子邮件经过验证
被引用次数：131022
Tumor Immunology Cancer Immunotherapy Interferon-gamma Cytokine Receptor Signaling Cytokine Biology
Paolo A. Ascierto

Paolo A. Ascierto

Istituto Nazionale Tumori Fondazione "G. Pascale", Napoli, Italy
在 istitutotumori.na.it 的电子邮件经过验证
被引用次数：107830
Melanoma Skin Cancer Cancer Immunotherapy Innovative Therapies
Luis A. Diaz Jr.

Luis A. Diaz Jr.

Memorial Sloan Kettering Cancer Center
在 mskcc.org 的电子邮件经过验证
被引用次数：99634
Cancer Circulating tumor DNA Cancer immunotherapy Colorectal cancer
George Coukos

George Coukos

University Hospital of Lausanne, Ludwig Institute for Cancer Research
在 chuv.ch 的电子邮件经过验证
被引用次数：83696
Cancer Immunotherapy
Jay Berzofsky

Jay Berzofsky

Chief, Vaccine Branch, CCR, NCI, NIH
在 mail.nih.gov 的电子邮件经过验证
被引用次数：52433
Immunology vaccines cancer immunotherapy HIV/AIDS
Pittet Mikael

Pittet Mikael

Professor, University of Geneva; Full Member, Ludwig Institute
在 unige.ch 的电子邮件经过验证
被引用次数：49572
Tumor Immunology Cancer Immunotherapy Myeloid Cells
Daniel S Chen

Daniel S Chen

Engenuity Life Sciences
在 engenuitylife.com 的电子邮件经过验证
被引用次数：43711
Cancer Immunotherapy Engineered Therapeutics Clinical Development Cell Therapy Coronavirus
Graham Pawelec

Graham Pawelec

Professor of Experimental Immunology
在 uni-tuebingen.de 的电子邮件经过验证
被引用次数：42668
cancer immunotherapy immunosenescence
Jon M Wigginton

Jon M Wigginton

President, Research and Developmen, Bright Peak Therapeutics
在 brightpeaktx.com 的电子邮件经过验证
被引用次数：39082
Cancer Immunotherapy Checkpoint Inhibitor PD-1 Bispecific Cytokine
Wenjun Ouyang

Wenjun Ouyang

Gilead Sciences Inc.
在 gilead.com 的电子邮件经过验证
被引用次数：37384
T cells Cytokines Cancer immunotherapy
1 - 10